Letter to the Editor
A Reflection on How We Define, Determine and Interpret the Finding of Lupus Anticoagulant
Una reflexión sobre el anticoagulante lúpico: cómo lo definimos, determinamos e interpretamos
Read
11459
Timeswas read the article
2289
Total PDF
9170
Total HTML
Share statistics
array:24 [ "pii" => "S2173574318300248" "issn" => "21735743" "doi" => "10.1016/j.reumae.2017.04.004" "estado" => "S300" "fechaPublicacion" => "2018-03-01" "aid" => "1060" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2018;14:120-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 4 "formatos" => array:2 [ "HTML" => 1 "PDF" => 3 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X17301055" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2017.04.013" "estado" => "S300" "fechaPublicacion" => "2018-03-01" "aid" => "1060" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2018;14:120-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 23222 "formatos" => array:3 [ "EPUB" => 191 "HTML" => 21107 "PDF" => 1924 ] ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Una reflexión sobre el anticoagulante lúpico: cómo lo definimos, determinamos e interpretamos" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "120" "paginaFinal" => "122" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "A reflection on how we define, determine and interpret the finding of lupus anticoagulant" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1731 "Ancho" => 3008 "Tamanyo" => 306949 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Detección, interpretación y posibles consecuencias clínicas de la positividad del anticoagulante lúpico.</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">AcL: anticoagulante lúpico; Anti-CL: anticardiolipina; Anti-β2GPI: anti- β2 glicoproteína <span class="elsevierStyleSmallCaps">i</span>; dRVVT: tiempo de veneno de víbora de Russell diluido; FL: fosfolípido; Ig: inmunoglobulina; TTP-a: tiempo de tromboplastina parcial activado.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Lara Valor, Diana Hernández-Flórez, Julia Martínez-Barrio, Francisco Javier López Longo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Lara" "apellidos" => "Valor" ] 1 => array:2 [ "nombre" => "Diana" "apellidos" => "Hernández-Flórez" ] 2 => array:2 [ "nombre" => "Julia" "apellidos" => "Martínez-Barrio" ] 3 => array:2 [ "nombre" => "Francisco Javier" "apellidos" => "López Longo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574318300248" "doi" => "10.1016/j.reumae.2017.04.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300248?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17301055?idApp=UINPBA00004M" "url" => "/1699258X/0000001400000002/v1_201803080430/S1699258X17301055/v1_201803080430/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574318300273" "issn" => "21735743" "doi" => "10.1016/j.reumae.2017.04.005" "estado" => "S300" "fechaPublicacion" => "2018-03-01" "aid" => "1057" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2018;14:122-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Prevalence of Risk Factors for the Development of Avascular Hip Necrosis in a Third-level Hospital" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "122" "paginaFinal" => "123" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Prevalencia de los factores de riesgo para el desarrollo de necrosis avascular de cadera en un hospital de tercer nivel" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Elena Cristina de Sautu de Borbón, Montserrat Morales Conejo, Juan Manuel Guerra Vales" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Elena Cristina" "apellidos" => "de Sautu de Borbón" ] 1 => array:2 [ "nombre" => "Montserrat" "apellidos" => "Morales Conejo" ] 2 => array:2 [ "nombre" => "Juan Manuel" "apellidos" => "Guerra Vales" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X1730102X" "doi" => "10.1016/j.reuma.2017.04.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X1730102X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300273?idApp=UINPBA00004M" "url" => "/21735743/0000001400000002/v1_201803210429/S2173574318300273/v1_201803210429/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574318300261" "issn" => "21735743" "doi" => "10.1016/j.reumae.2017.05.004" "estado" => "S300" "fechaPublicacion" => "2018-03-01" "aid" => "1064" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2018;14:119-20" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Web-like bronchial stenosis secondary to granulomatosis with polyangiitis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "119" "paginaFinal" => "120" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estenosis bronquiales <span class="elsevierStyleItalic">web-like</span> secundarias a granulomatosis con poliangeitis" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1737 "Ancho" => 3008 "Tamanyo" => 290379 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Bronchoscopic image showing a web-like concentric membranous stenosis that crosses the entrance to the base of right lower lobe, with a minimal central aperture that impedes the passage of the bronchoscope to the distal region. In left bronchus, the same stenosis but with a larger central aperture.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Catalina Ulloa-Clavijo, Miguel Ariza-Prota, Manuel Vaquero-Cacho, Luis Caminal-Montero" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Catalina" "apellidos" => "Ulloa-Clavijo" ] 1 => array:2 [ "nombre" => "Miguel" "apellidos" => "Ariza-Prota" ] 2 => array:2 [ "nombre" => "Manuel" "apellidos" => "Vaquero-Cacho" ] 3 => array:2 [ "nombre" => "Luis" "apellidos" => "Caminal-Montero" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X17301237" "doi" => "10.1016/j.reuma.2017.05.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17301237?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300261?idApp=UINPBA00004M" "url" => "/21735743/0000001400000002/v1_201803210429/S2173574318300261/v1_201803210429/en/main.assets" ] "en" => array:16 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "A Reflection on How We Define, Determine and Interpret the Finding of Lupus Anticoagulant" "tieneTextoCompleto" => true "saludo" => "To the Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "120" "paginaFinal" => "122" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Lara Valor, Diana Hernández-Flórez, Julia Martínez-Barrio, Francisco Javier López Longo" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Lara" "apellidos" => "Valor" "email" => array:1 [ 0 => "lvalor.hgugm@salud.madrid.org" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Diana" "apellidos" => "Hernández-Flórez" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Julia" "apellidos" => "Martínez-Barrio" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Francisco Javier" "apellidos" => "López Longo" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Reumatología, Hospital General Universitario Gregorio Marañón, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Instituto de Investigación Biomédica, Hospital Gregorio Marañón, Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Una reflexión sobre el anticoagulante lúpico: cómo lo definimos, determinamos e interpretamos" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1737 "Ancho" => 3008 "Tamanyo" => 290379 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Detection, interpretation and possible clinical consequences of a positive result in lupus anticoagulant testing. aCL, anti-cardiolipin; anti-β2GPI, anti-β2-glycoprotein <span class="elsevierStyleSmallCaps">i</span>; aPTT, activated partial thromboplastin time; dRVVT, dilute Russell's viper venom time; Ig, immunoglobulin; LA, lupus anticoagulant; PL, phospholipid.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">International criteria for the diagnosis of antiphospholipid syndrome (APS) include the detection of antiphospholipid antibodies: anticardiolipin and anti-β2-glycoprotein <span class="elsevierStyleSmallCaps">i</span> (anti-β2GPI) of immunoglobulin (Ig) G and IgM isotopes and lupus anticoagulant (LA), and its detection in patients with a history of thrombosis or pregnancy complications is considered to be essential in the management of APS.<a class="elsevierStyleCrossRefs" href="#bib0070"><span class="elsevierStyleSup">1–3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">During the 1950s, it became evident that patients with systemic lupus erythematosus (SLE) had a circulating anticoagulant factor, and the concept of LA was coined to designate a heterogenic group of coagulation inhibitors that affect prothrombin activation by the prothrombinase enzyme complex.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">4</span></a> Lupus anticoagulant is currently described as an Ig like IgG/IgM that inhibits phospholipid (PL)-dependent coagulation reactions <span class="elsevierStyleItalic">in vitro</span>. However, is LA always associated with SLE? Does it inhibit coagulation? Is it an antibody? First, the majority of the patients who are positive for LA do not have SLE. In the absence of concomitant thrombocytopenia or a deficiency of coagulation factors or inhibitors of coagulation factors, with certain exceptions, LA is related to processes of hypercoagulability and arterial and venous thrombosis, but is not, <span class="elsevierStyleItalic">per se</span>, a risk factor for bleeding or hemorrhage. With the currently available scientific evidence, it can be said the LA is constituted by a group of antibodies that have yet to be characterized.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">5,6</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Lupus anticoagulant is detected using functional assays that demonstrate a PL-dependent prolongation of the clotting time, due to the <span class="elsevierStyleItalic">in vitro</span> interference of antibodies with PL-dependent function, as with certain essential cofactors in the coagulation cascade (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>) that result in the prolongation of the activated partial thromboplastin time. The International Society on Thrombosis and Haemostasis (ISTH),<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">7</span></a> a society that has unsuccessfully attempted to change the name, established the following criteria to confirm the presence of LA:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">1.</span><p id="par0020" class="elsevierStylePara elsevierViewall">Phospholipid-dependent prolonged coagulation tests.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">2.</span><p id="par0025" class="elsevierStylePara elsevierViewall">Demonstration of the coagulation inhibitor utilizing mixed plasma.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">3.</span><p id="par0030" class="elsevierStylePara elsevierViewall">Demonstration of the PL dependence of the inhibitor.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">4.</span><p id="par0035" class="elsevierStylePara elsevierViewall">Ruling out other coagulation disorders, particularly due to deficiency of coagulation factors.</p></li></ul></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">Lupus anticoagulant can be detected in patients with SLE, and with other autoimmune diseases, infections like human immunodeficiency virus, hepatitis and malaria, neoplastic disease or those taking certain drugs (procainamide and chlorpromazine).<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">6,8</span></a> A prevalence of 5% has been reported in the general adult population and up to 9.5% in women of reproductive age. Although the pathogenic mechanism has not been defined, the presence of LA has been related to stroke, transitory ischemic attack, acquired thrombophilia and obstetric events, like early and/or recurrent pregnancy loss.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">7</span></a> Although it is certain that, in general, antiphospholipid antibodies have been associated with the clinical manifestations of APS, this association seems to be more evident with LA both in thrombosis and in the morbidity related to pregnancy.<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">8,9</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">Studies dealing with the relationship between the processes of coagulation and inflammation would establish the clinical relevance of the detection of LA alone, as well as the emergent association of LA to C-reactive protein and mortality. The therapeutic management of asymptomatic carriers of LA could require prophylactic treatment given the presence of cardiovascular risk factors or autoimmune disease.<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">5,8</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">In view of the potential thrombotic risk in patients who are positive for LA, it is essential to develop an accurate method for performing its assessment in terms of the diagnosis and follow-up of these patients and the decision on the anticoagulant therapy they should receive. Unfortunately, since we lack a technique to serve as a reference for the detection of LA, laboratories utilize heterogeneous and non-quantitative assays, impeding the characterization of positive results in terms of low or elevated titers.<a class="elsevierStyleCrossRefs" href="#bib0115"><span class="elsevierStyleSup">10,11</span></a> This requires that the validation of the results be performed only by expert staff. In turn, it impedes their being standardized, the establishment of a consensus and the automation of this determination.<a class="elsevierStyleCrossRefs" href="#bib0095"><span class="elsevierStyleSup">6,11</span></a> A study published by Devreese et al. points out the need to analyze other additional procoagulant markers, like P-selectin (a marker of platelet activation) and coagulation factor <span class="elsevierStyleSmallCaps">vii</span> in patients with weak LA, in order to optimize its clinical utility.<a class="elsevierStyleCrossRefs" href="#bib0125"><span class="elsevierStyleSup">12,13</span></a> It is evident that both overrating and underrating LA would expose our patients to long-term anticoagulation or to an increase in the risk of recurrent thrombosis, respectively.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">13</span></a> Likewise, it should be possible to report LA quantitatively to enable the identification of low titers or those near the reference value. There is an unquestionable need to perform prospective studies, that examine the relevance of these laboratory tests. This, together with possible new prognostic laboratory parameters, would help in the stratification of the patients in accordance with the risk groups and in making therapeutic decisions.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Valor L, Hernández-Flórez D, Martínez-Barrio J, López Longo FJ. Una reflexión sobre el anticoagulante lúpico: cómo lo definimos, determinamos e interpretamos. Reumatol Clin. 2018;14:120–122.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1737 "Ancho" => 3008 "Tamanyo" => 290379 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Detection, interpretation and possible clinical consequences of a positive result in lupus anticoagulant testing. aCL, anti-cardiolipin; anti-β2GPI, anti-β2-glycoprotein <span class="elsevierStyleSmallCaps">i</span>; aPTT, activated partial thromboplastin time; dRVVT, dilute Russell's viper venom time; Ig, immunoglobulin; LA, lupus anticoagulant; PL, phospholipid.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:13 [ 0 => array:3 [ "identificador" => "bib0070" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "W.A. Wilson" 1 => "A.E. Gharavi" 2 => "T. Koike" 3 => "M.D. Lockshin" 4 => "D.W. Branch" 5 => "J.C. Piette" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1999" "volumen" => "42" "paginaInicial" => "1309" "paginaFinal" => "1311" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10403256" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0075" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Miyakis" 1 => "M.D. Lockshin" 2 => "T. Atsumi" 3 => "D.W. Branch" 4 => "R.L. Brey" 5 => "R. Cervera" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Thromb Haemostasis" "fecha" => "2006" "volumen" => "4" "paginaInicial" => "295" "paginaFinal" => "306" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0080" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "How we diagnose and treat manifestations of the antiphospholipid syndrome: a case-based review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D. Garcia" 1 => "M. Khamashta" 2 => "M. Crowther" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1182/blood-2006-10-041814" "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "2007" "volumen" => "110" "paginaInicial" => "3122" "paginaFinal" => "3127" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17644740" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0085" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acquired inhibitors of blood coagulation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.I. Feinstein" 1 => "S.I. Rapaport" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Prog Hemost Thromb" "fecha" => "1972" "volumen" => "1" "paginaInicial" => "75" "paginaFinal" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4569725" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0090" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New tests to detect antiphospholipid antibodies: anti-domain I beta-2-glyco- protein-I antibodies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C.B. Chighizola" 1 => "M. Gerosa" 2 => "P.L. Meroni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11926-013-0402-7" "Revista" => array:6 [ "tituloSerie" => "Curr Rheumatol Rep" "fecha" => "2014" "volumen" => "16" "paginaInicial" => "402" "paginaFinal" => "409" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24390756" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0095" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The challenges of lupus anticoagulants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.B. Chighizola" 1 => "E. Raschi" 2 => "A. Banzato" 3 => "M.O. Borghi" 4 => "V. Pengo" 5 => "P.L. Meroni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1586/17474086.2016.1140034" "Revista" => array:6 [ "tituloSerie" => "Expert Rev Hematol" "fecha" => "2016" "volumen" => "9" "paginaInicial" => "389" "paginaFinal" => "400" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26789237" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0100" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Pengo" 1 => "A. Tripodi" 2 => "G. Reber" 3 => "J.H. Rand" 4 => "T.L. Ortel" 5 => "M. Galli" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1538-7836.2009.03555.x" "Revista" => array:6 [ "tituloSerie" => "J Thromb Haemost" "fecha" => "2009" "volumen" => "7" "paginaInicial" => "1737" "paginaFinal" => "1740" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19624461" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0105" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. Andreoli" 1 => "C.B. Chighizola" 2 => "A. Banzato" 3 => "G.J. Pons-Estel" 4 => "G. Ramire de Jesus" 5 => "D. Erkan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arthritis Care Res" "fecha" => "2013" "volumen" => "65" "paginaInicial" => "1869" "paginaFinal" => "1873" ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0110" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Q. Reynaud" 1 => "J.C. Lega" 2 => "P. Mismetti" 3 => "C. Chapelle" 4 => "D. Wahl" 5 => "P. Cathébras" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.autrev.2013.11.004" "Revista" => array:6 [ "tituloSerie" => "Autoimmun Rev" "fecha" => "2014" "volumen" => "13" "paginaInicial" => "595" "paginaFinal" => "608" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24418303" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0115" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.T. Pennings" 1 => "P.G. De Groot" 2 => "J.C. Meijers" 3 => "A. Huisman" 4 => "R.H. Derksen" 5 => "R.T. Urbanus" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1160/TH14-02-0122" "Revista" => array:6 [ "tituloSerie" => "Thromb Haemost" "fecha" => "2014" "volumen" => "112" "paginaInicial" => "736" "paginaFinal" => "742" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25008787" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0120" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus anticoagulant assays: questions answered and to be answered" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Teruya" 1 => "A.G. West" 2 => "M.N. Suell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1043/1543-2165(2007)131[885:LAAQAA]2.0.CO;2" "Revista" => array:6 [ "tituloSerie" => "Arch Pathol Lab Med" "fecha" => "2007" "volumen" => "131" "paginaInicial" => "885" "paginaFinal" => "889" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17550315" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0125" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mixing studies in lupus anticoagulant testing are required at least in some type of samples" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K.M. Devreese" 1 => "B. de Laat" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jth.13020" "Revista" => array:6 [ "tituloSerie" => "J Thromb Haemost" "fecha" => "2015" "volumen" => "13" "paginaInicial" => "1475" "paginaFinal" => "1478" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26017873" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0130" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K. Devreese" 1 => "K. Peerlinck" 2 => "M.F. Hoylaerts" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1182/blood-2009-09-244426" "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "2010" "volumen" => "115" "paginaInicial" => "870" "paginaFinal" => "878" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19965629" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack339327" "titulo" => "Acknowledgments" "texto" => "<p id="par0055" class="elsevierStylePara elsevierViewall">The authors wish to thank Dr. Nora Butta (Laboratory for Research on Coagulopathies and Hemostatic Disorders, Hematology Unit, Hospital Universitario La Paz-IDIPaz, Madrid, Spain) for her critical reading and the corrections she made in this manuscript.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001400000002/v1_201803210429/S2173574318300248/v1_201803210429/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001400000002/v1_201803210429/S2173574318300248/v1_201803210429/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300248?idApp=UINPBA00004M" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 6 | 1 | 7 |
| 2024 October | 86 | 28 | 114 |
| 2024 September | 102 | 35 | 137 |
| 2024 August | 132 | 50 | 182 |
| 2024 July | 108 | 38 | 146 |
| 2024 June | 132 | 46 | 178 |
| 2024 May | 234 | 34 | 268 |
| 2024 April | 141 | 35 | 176 |
| 2024 March | 213 | 36 | 249 |
| 2024 February | 218 | 25 | 243 |
| 2024 January | 256 | 30 | 286 |
| 2023 December | 259 | 39 | 298 |
| 2023 November | 241 | 20 | 261 |
| 2023 October | 278 | 57 | 335 |
| 2023 September | 238 | 55 | 293 |
| 2023 August | 207 | 24 | 231 |
| 2023 July | 214 | 30 | 244 |
| 2023 June | 207 | 40 | 247 |
| 2023 May | 295 | 44 | 339 |
| 2023 April | 193 | 22 | 215 |
| 2023 March | 242 | 40 | 282 |
| 2023 February | 148 | 38 | 186 |
| 2023 January | 155 | 22 | 177 |
| 2022 December | 172 | 55 | 227 |
| 2022 November | 186 | 51 | 237 |
| 2022 October | 166 | 51 | 217 |
| 2022 September | 162 | 53 | 215 |
| 2022 August | 165 | 51 | 216 |
| 2022 July | 167 | 60 | 227 |
| 2022 June | 202 | 50 | 252 |
| 2022 May | 216 | 58 | 274 |
| 2022 April | 214 | 56 | 270 |
| 2022 March | 218 | 66 | 284 |
| 2022 February | 217 | 48 | 265 |
| 2022 January | 270 | 63 | 333 |
| 2021 December | 194 | 56 | 250 |
| 2021 November | 157 | 70 | 227 |
| 2021 October | 155 | 70 | 225 |
| 2021 September | 141 | 58 | 199 |
| 2021 August | 158 | 52 | 210 |
| 2021 July | 132 | 36 | 168 |
| 2021 June | 191 | 34 | 225 |
| 2021 May | 171 | 61 | 232 |
| 2021 April | 346 | 100 | 446 |
| 2021 March | 167 | 48 | 215 |
| 2021 February | 118 | 32 | 150 |
| 2021 January | 116 | 33 | 149 |
| 2020 December | 118 | 24 | 142 |
| 2020 November | 74 | 35 | 109 |
| 2020 October | 51 | 13 | 64 |
| 2020 September | 51 | 28 | 79 |
| 2020 August | 32 | 15 | 47 |
| 2020 July | 12 | 12 | 24 |
| 2020 June | 43 | 23 | 66 |
| 2020 May | 31 | 11 | 42 |
| 2020 April | 34 | 15 | 49 |
| 2020 March | 16 | 9 | 25 |
| 2020 February | 2 | 0 | 2 |
| 2018 November | 0 | 1 | 1 |
| 2018 October | 0 | 1 | 1 |
| 2018 April | 0 | 1 | 1 |
Show all
